Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Make Aurora Cannabis Front and Center in Your Pot-folio

By David Moadel, InvestorPlace Contributor
Ignore the haters. Aurora Cannabis isn't headed to zero anytime soon. In fact it might just become the cannabis market's hero in 2020.

10 Best Stocks to Beat the Market in 2020

By Marie Brodbeck, InvestorPlace Contributor
2020 is likely to offer investors more volatility, but these 10 stocks look poised to deliver over the next 12 months.

Aurora Stock Dove After an Analyst Gave It a $0 Price Target

By Brad Moon, InvestorPlace Contributor
Aurora stock took another hit on Monday after a research analyst set a $0 price target on ACB stock, citing high debt and high supply.

Why Canopy Growth Stock is a Buy Today as Cannabis’ Bad Year Nears End

By Chris Tyler, InvestorPlace Contributor
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble

Pair-Trading Cannabis Stocks: Go Long THC and Short CBD

By Wayne Duggan, InvestorPlace Contributor
Cannabis stocks have taken a huge hit in 2019 and will likely remain volatile while the industry goes through its growing pains. Long-term cannabis bulls can consider mitigating their portfolio risk by going long top legal cannabis producers and short CBD-focused stocks.

It Doesn’t Look as If 2020 Will Be Any Better for Hexo Stock

By Faisal Humayun, InvestorPlace Contributor
Cash burn will result in equity dilution. Slower growth likely in medicinal and recreational cannabis due to regulatory headwinds.

A Close Look Shows New Age Beverages Stock Remains a Sell

By Vince Martin, InvestorPlace Contributor
NBEV stock is intriguing as its revenue is growing and it has a CBD opportunity. But NBEV is failing to deliver on its promise.

Canopy Growth Is Halfway to a Full Blown Recovery

By Marie Brodbeck, InvestorPlace Contributor
Investors who are looking for marijuana stocks should have CGC on their radar as it looks like the best of the bunch right now.

Aurora Cannabis Will Survive, But It’s Still a Poor Investment

By Ian Bezek, InvestorPlace Contributor
Aurora Cannabis isn't going to go bankrupt soon, so don't worry about that. But those fears show just how far it has fallen.

3 Medical Marijuana Stocks to Buy

By Vince Martin, InvestorPlace Contributor
The best stocks in the pot sector might be the medical marijuana plays. These 3 medical marijuana stocks should have big upside.

Canopy Growth Stock Rally Should Offer Many Trading Opportunities

By Nicolas Chahine, InvestorPlace Contributor
There are profits in trading Canopy Growth stock as the sector finds its footing on Wall Street. CGC is in a rebound effort from earnings.

Why There’s No Rush to Buy Tilray Stock Anytime Soon

By Luke Lango, InvestorPlace Senior Investment Analyst
TLRY stock is down big since the passage of the MORE Act, and that's a sign of more troubles to come for Tilray stock.

With a Cloudy Future and Shaky Financials, NBEV Stock Is a Falling Knife

By Marie Brodbeck, InvestorPlace Contributor
At this point NBEV stock looks like a falling knife with very little upside potential.

Canopy Growth Stock Popped — What’s Going On?

By Brad Moon, InvestorPlace Contributor
Canopy Growth stock has enjoyed a rare week of good news. But investors should hold off on buying CGC stock for now.

Canopy Growth Needs You to Call the Cops

By Dana Blankenhorn, InvestorPlace Contributor
Canopy Growth hopes that infusing chocolate with THC will deliver high sales that legal bud hasn't under new CEO David Klein.

Can Cronos Stock Break Out of Its Downtrend?

By Bret Kenwell, InvestorPlace Contributor
Cronos stock is surviving thanks to its large cash balance. However, can CRON stock finally turn the corner and snap out of its funk?

Patience With Aurora Cannabis Will Pay Off in 2020

By Luke Lango, InvestorPlace Senior Investment Analyst
Presently depressed Canadian consumer cannabis demand trends could reverse in 2020. If they do, Aurora Cannabis could rebound in a big way.

Consider Aphria Stock as the Cannabisphere Burns

By Thomas Niel, InvestorPlace Contributor
But does this make APHA stock a buy today? Perhaps. Analyst consensus projects positive earnings-per-share for Aphria stock in 2020 and 2021. Meanwhile, the above-mentioned peers will remain unprofitable. The bigger names dominate the headlines. But under-the-radar Aphria may be the best "pot stock" buy.

Why Investors Should Continue to Say No to Hexo Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
At the end of the day, the cannabis industry will birth only 5 to 10 big winners, and HEXO stock likely won't be one of them.
Load More